| 1 | antagonist | 4,813 |
| 2 | agonist | 3,687 |
| 3 | diphosphate | 258 |
| 4 | triphosphate | 233 |
| 5 | mimetic | 111 |
| 6 | two-hybrid | 87 |
| 7 | deaminase | 60 |
| 8 | -blocker | 34 |
| 9 | triphosphatase | 33 |
| 10 | 5'-monophosphate | 26 |
| 11 | agonist/antagonist | 24 |
| 12 | 5'-triphosphate | 23 |
| 13 | diphosphate-induced | 21 |
| 14 | pantotrichum | 21 |
| 15 | antagonist-based | 14 |
| 16 | agonist-antagonist | 13 |
| 17 | 3',5'-monophosphate | 12 |
| 18 | beta-hydroxylase | 11 |
| 19 | releaser | 11 |
| 20 | -antihistamine | 10 |
| 21 | pranobex | 10 |
| 22 | subtype-3 | 10 |
| 23 | alpha-antagonist | 9 |
| 24 | coagonist | 9 |
| 25 | β-hydroxylase | 9 |
| 26 | 5'-diphosphate | 7 |
| 27 | l335 | 7 |
| 28 | p335l | 7 |
| 29 | =-0.46 | 6 |
| 30 | triphosphate-dependent | 6 |
| 31 | =-0.53 | 5 |
| 32 | agonist-evoked | 5 |
| 33 | allyloxy | 5 |
| 34 | bubali | 5 |
| 35 | diphosphate-ribose | 5 |
| 36 | down-regulator | 5 |
| 37 | elaphuri | 5 |
| 38 | one-hybrid | 5 |
| 39 | =-0.52 | 4 |
| 40 | =-0.56 | 4 |
| 41 | =-0.62 | 4 |
| 42 | non-ebm | 4 |
| 43 | p335 | 4 |
| 44 | phosphate-mediated | 4 |
| 45 | -1438 | 3 |
| 46 | =-0.39 | 3 |
| 47 | antagonist-assisted | 3 |
| 48 | diphosphate- | 3 |
| 49 | down-regulators | 3 |
| 50 | fold-shift | 3 |
| 51 | monophosphate-dependent | 3 |
| 52 | receptor-antagonist | 3 |
| 53 | receptor-rich | 3 |
| 54 | s-releasing | 3 |
| 55 | soja | 3 |
| 56 | t102c | 3 |
| 57 | 1-activating | 2 |
| 58 | 3׳,5׳-monophosphate | 2 |
| 59 | 5'-diphosphocholine | 2 |
| 60 | 9-activating | 2 |
| 61 | =-0.22 | 2 |
| 62 | =-0.34 | 2 |
| 63 | =-0.42 | 2 |
| 64 | =-0.57 | 2 |
| 65 | a-1438g | 2 |
| 66 | alchemist | 2 |
| 67 | alpha2-antagonist | 2 |
| 68 | antagonist/letrozole | 2 |
| 69 | beta-selective | 2 |
| 70 | d3-preferring | 2 |
| 71 | diphosphatase | 2 |
| 72 | diphosphate-glucuronosyltransferase | 2 |
| 73 | diphosphate-mediated | 2 |
| 74 | h2-antagonist | 2 |
| 75 | la-40 | 2 |
| 76 | m1-antagonist | 2 |
| 77 | partial-agonist | 2 |
| 78 | r=-.40 | 2 |
| 79 | receptor-sensitive | 2 |
| 80 | receptor/cell | 2 |
| 81 | tri-phosphate | 2 |
| 82 | triphosphate-induced | 2 |
| 83 | xylidide | 2 |
| 84 | γ-stimulating | 2 |
| 85 | +0.459 | 1 |
| 86 | +0.500 | 1 |
| 87 | +0.585 | 1 |
| 88 | -antagonistic | 1 |
| 89 | -lean | 1 |
| 90 | .high-dose | 1 |
| 91 | /5-ht7 | 1 |
| 92 | 0·424 | 1 |
| 93 | 0·461 | 1 |
| 94 | 0·475 | 1 |
| 95 | 0·599 | 1 |
| 96 | 0·961 | 1 |
| 97 | 1.73-4.27 | 1 |
| 98 | 1=0.0698 | 1 |
| 99 | 1a-like | 1 |
| 100 | 2-activating | 1 |
| 101 | 2-agonistic | 1 |
| 102 | 2-hybrid | 1 |
| 103 | 2-prostaglandin | 1 |
| 104 | 2.10.1 | 1 |
| 105 | 2/centromeric | 1 |
| 106 | 2=0.31 | 1 |
| 107 | 3',5'-bis | 1 |
| 108 | 3'5'-monophosphate | 1 |
| 109 | 3':5'-monophosphate-phosphodiesterase | 1 |
| 110 | 3-1724 | 1 |
| 111 | 3-agonist | 1 |
| 112 | 3-phosphonylated | 1 |
| 113 | 4/nuclear | 1 |
| 114 | 4glcnac | 1 |
| 115 | 5'-3-o- | 1 |
| 116 | 5'-diphospate-glucuronosyltransferase | 1 |
| 117 | 5'-diphosphate-glucuronosyltransferases | 1 |
| 118 | 5'-diphosphate-induced | 1 |
| 119 | 5'-diphosphate-n-acetylglucosamine | 1 |
| 120 | 5'-diphosphoribose | 1 |
| 121 | 5'phosphosulfate | 1 |
| 122 | 5-diphosphate | 1 |
| 123 | 5′-monophosphate | 1 |
| 124 | =-0.08 | 1 |
| 125 | =-0.12 | 1 |
| 126 | =-0.26 | 1 |
| 127 | =-0.3 | 1 |
| 128 | =-0.307 | 1 |
| 129 | =-0.408 | 1 |
| 130 | =-0.411 | 1 |
| 131 | =-0.466 | 1 |
| 132 | =-0.50 | 1 |
| 133 | =-0.527 | 1 |
| 134 | =-0.529 | 1 |
| 135 | =-0.55 | 1 |
| 136 | =-0.569 | 1 |
| 137 | =-0.583 | 1 |
| 138 | =-0.624 | 1 |
| 139 | =-0.68 | 1 |
| 140 | =-0.686 | 1 |
| 141 | =-0.730 | 1 |
| 142 | =-0.766 | 1 |
| 143 | =-0.78 | 1 |
| 144 | =-0.843 | 1 |
| 145 | =-0.87 | 1 |
| 146 | =.137 | 1 |
| 147 | =.157 | 1 |
| 148 | =.190 | 1 |
| 149 | =.492 | 1 |
| 150 | =.504 | 1 |
| 151 | =.89 | 1 |
| 152 | =0.275 | 1 |
| 153 | =0.301 | 1 |
| 154 | =0.339 | 1 |
| 155 | =0.39-0.59 | 1 |
| 156 | =0.660 | 1 |
| 157 | =0.679 | 1 |
| 158 | =0.711 | 1 |
| 159 | =0.801 | 1 |
| 160 | =0.890 | 1 |
| 161 | =16.1 | 1 |
| 162 | =20.35 | 1 |
| 163 | =5.793 | 1 |
| 164 | =6.166 | 1 |
| 165 | a3beta | 1 |
| 166 | activity-staining | 1 |
| 167 | agonist-based | 1 |
| 168 | agonist-long | 1 |
| 169 | agonist-possibly | 1 |
| 170 | agonist/hmg | 1 |
| 171 | agonist/n-methyl-d-aspartate | 1 |
| 172 | agonist/δ-opioid | 1 |
| 173 | ammonis1 | 1 |
| 174 | antagonist+dexamethasone | 1 |
| 175 | antagonist+dexamethasone+aprepitant | 1 |
| 176 | antagonist-exposed | 1 |
| 177 | antagonist/long-acting | 1 |
| 178 | antagonist/nicotine | 1 |
| 179 | antagonists-sb-269970 | 1 |
| 180 | antagonists-treated | 1 |
| 181 | aspersum | 1 |
| 182 | beta-1,3/1,6-d-glucan | 1 |
| 183 | blocker-arb | 1 |
| 184 | blockers-based | 1 |
| 185 | bread/rolls | 1 |
| 186 | cd36-related | 1 |
| 187 | channel-activator | 1 |
| 188 | co-agonists | 1 |
| 189 | contanining | 1 |
| 190 | covaginal | 1 |
| 191 | cox-2-inhibitory | 1 |
| 192 | cox=0.065 | 1 |
| 193 | cox=0.126 | 1 |
| 194 | daspartate | 1 |
| 195 | deaminases | 1 |
| 196 | degelatinatum | 1 |
| 197 | delta32 | 1 |
| 198 | der1p | 1 |
| 199 | diethanolamine | 1 |
| 200 | differentialt | 1 |
| 201 | diphosphate-choline | 1 |
| 202 | diphosphate-glucosyltransferase | 1 |
| 203 | diphosphate-inducible | 1 |
| 204 | diphosphate-n-acetyl-d-glucosamine | 1 |
| 205 | diphosphate-n-acetylglucosamine | 1 |
| 206 | epimerase | 1 |
| 207 | err-α-mediated | 1 |
| 208 | f2α-based | 1 |
| 209 | gammaagonists | 1 |
| 210 | haloalkyl | 1 |
| 211 | hye | 1 |
| 212 | i1-receptors | 1 |
| 213 | immunocontraception | 1 |
| 214 | imvac=0.2 | 1 |
| 215 | imvac=0.8 | 1 |
| 216 | incretion | 1 |
| 217 | ko-mice | 1 |
| 218 | levels.among | 1 |
| 219 | macrorhabdus | 1 |
| 220 | mage-3243-258 | 1 |
| 221 | monophospate | 1 |
| 222 | monophosphate-mediated | 1 |
| 223 | monophosphate.mg | 1 |
| 224 | mother-bud | 1 |
| 225 | mri-adaptation | 1 |
| 226 | mullite-type | 1 |
| 227 | mutants-r859h | 1 |
| 228 | nacl/l | 1 |
| 229 | neuromodulator/receptor | 1 |
| 230 | neurone-blocking | 1 |
| 231 | o-co2 | 1 |
| 232 | ofq | 1 |
| 233 | pancreatic-pituitary | 1 |
| 234 | paranitro | 1 |
| 235 | positive/progesterone | 1 |
| 236 | pr+/pr- | 1 |
| 237 | production/oxidation | 1 |
| 238 | pyrene/fe | 1 |
| 239 | r2=.17 | 1 |
| 240 | receptor-antagonistic | 1 |
| 241 | receptor-beta2-agonist | 1 |
| 242 | receptor-is | 1 |
| 243 | receptorinhibitor | 1 |
| 244 | receptors-dependent | 1 |
| 245 | receptors-has | 1 |
| 246 | response/pr | 1 |
| 247 | rhinoceri | 1 |
| 248 | rice-extract | 1 |
| 249 | s10ph | 1 |
| 250 | saccharomycopsis | 1 |
| 251 | site/alpha | 1 |
| 252 | square=0.058 | 1 |
| 253 | squared=0.025 | 1 |
| 254 | squared=0.072 | 1 |
| 255 | squared=0.090 | 1 |
| 256 | squared=0.092 | 1 |
| 257 | squared=0.112 | 1 |
| 258 | squared=0.114 | 1 |
| 259 | ss-hydroxylase | 1 |
| 260 | subtype-5 | 1 |
| 261 | sympathicotomies | 1 |
| 262 | three-hybrid | 1 |
| 263 | transporter-2 | 1 |
| 264 | treatment× | 1 |
| 265 | triphosphate-citrate | 1 |
| 266 | triphosphate-competitive | 1 |
| 267 | triphosphate-sparing | 1 |
| 268 | triphosphate-stress | 1 |
| 269 | triphosphate-tumor | 1 |
| 270 | type-α | 1 |
| 271 | v11.2 | 1 |
| 272 | vps53p | 1 |
| 273 | wesnes | 1 |
| 274 | wild-type/m159c | 1 |
| 275 | α4β7-mediated | 1 |
| 276 | η2=.087 | 1 |
| 277 | η2=.107 | 1 |
| 278 | η2=.118 | 1 |
| 279 | η2=.199 | 1 |
| 280 | η2=0.005 | 1 |
| 281 | η²=0.12 | 1 |
| 282 | μ-agonist/κ-antagonist | 1 |
| 1 | +0.459 | 1 |
| 2 | +0.500 | 1 |
| 3 | +0.585 | 1 |
| 4 | -1438 | 3 |
| 5 | -antagonistic | 1 |
| 6 | -antihistamine | 10 |
| 7 | -blocker | 34 |
| 8 | -lean | 1 |
| 9 | .high-dose | 1 |
| 10 | /5-ht7 | 1 |
| 11 | 0·424 | 1 |
| 12 | 0·461 | 1 |
| 13 | 0·475 | 1 |
| 14 | 0·599 | 1 |
| 15 | 0·961 | 1 |
| 16 | 1-activating | 2 |
| 17 | 1.73-4.27 | 1 |
| 18 | 1=0.0698 | 1 |
| 19 | 1a-like | 1 |
| 20 | 2-activating | 1 |
| 21 | 2-agonistic | 1 |
| 22 | 2-hybrid | 1 |
| 23 | 2-prostaglandin | 1 |
| 24 | 2.10.1 | 1 |
| 25 | 2/centromeric | 1 |
| 26 | 2=0.31 | 1 |
| 27 | 3',5'-bis | 1 |
| 28 | 3',5'-monophosphate | 12 |
| 29 | 3'5'-monophosphate | 1 |
| 30 | 3':5'-monophosphate-phosphodiesterase | 1 |
| 31 | 3-1724 | 1 |
| 32 | 3-agonist | 1 |
| 33 | 3-phosphonylated | 1 |
| 34 | 3׳,5׳-monophosphate | 2 |
| 35 | 4/nuclear | 1 |
| 36 | 4glcnac | 1 |
| 37 | 5'-3-o- | 1 |
| 38 | 5'-diphospate-glucuronosyltransferase | 1 |
| 39 | 5'-diphosphate | 7 |
| 40 | 5'-diphosphate-glucuronosyltransferases | 1 |
| 41 | 5'-diphosphate-induced | 1 |
| 42 | 5'-diphosphate-n-acetylglucosamine | 1 |
| 43 | 5'-diphosphocholine | 2 |
| 44 | 5'-diphosphoribose | 1 |
| 45 | 5'-monophosphate | 26 |
| 46 | 5'-triphosphate | 23 |
| 47 | 5'phosphosulfate | 1 |
| 48 | 5-diphosphate | 1 |
| 49 | 5′-monophosphate | 1 |
| 50 | 9-activating | 2 |
| 51 | =-0.08 | 1 |
| 52 | =-0.12 | 1 |
| 53 | =-0.22 | 2 |
| 54 | =-0.26 | 1 |
| 55 | =-0.3 | 1 |
| 56 | =-0.307 | 1 |
| 57 | =-0.34 | 2 |
| 58 | =-0.39 | 3 |
| 59 | =-0.408 | 1 |
| 60 | =-0.411 | 1 |
| 61 | =-0.42 | 2 |
| 62 | =-0.46 | 6 |
| 63 | =-0.466 | 1 |
| 64 | =-0.50 | 1 |
| 65 | =-0.52 | 4 |
| 66 | =-0.527 | 1 |
| 67 | =-0.529 | 1 |
| 68 | =-0.53 | 5 |
| 69 | =-0.55 | 1 |
| 70 | =-0.56 | 4 |
| 71 | =-0.569 | 1 |
| 72 | =-0.57 | 2 |
| 73 | =-0.583 | 1 |
| 74 | =-0.62 | 4 |
| 75 | =-0.624 | 1 |
| 76 | =-0.68 | 1 |
| 77 | =-0.686 | 1 |
| 78 | =-0.730 | 1 |
| 79 | =-0.766 | 1 |
| 80 | =-0.78 | 1 |
| 81 | =-0.843 | 1 |
| 82 | =-0.87 | 1 |
| 83 | =.137 | 1 |
| 84 | =.157 | 1 |
| 85 | =.190 | 1 |
| 86 | =.492 | 1 |
| 87 | =.504 | 1 |
| 88 | =.89 | 1 |
| 89 | =0.275 | 1 |
| 90 | =0.301 | 1 |
| 91 | =0.339 | 1 |
| 92 | =0.39-0.59 | 1 |
| 93 | =0.660 | 1 |
| 94 | =0.679 | 1 |
| 95 | =0.711 | 1 |
| 96 | =0.801 | 1 |
| 97 | =0.890 | 1 |
| 98 | =16.1 | 1 |
| 99 | =20.35 | 1 |
| 100 | =5.793 | 1 |
| 101 | =6.166 | 1 |
| 102 | a-1438g | 2 |
| 103 | a3beta | 1 |
| 104 | activity-staining | 1 |
| 105 | agonist | 3,687 |
| 106 | agonist-antagonist | 13 |
| 107 | agonist-based | 1 |
| 108 | agonist-evoked | 5 |
| 109 | agonist-long | 1 |
| 110 | agonist-possibly | 1 |
| 111 | agonist/antagonist | 24 |
| 112 | agonist/hmg | 1 |
| 113 | agonist/n-methyl-d-aspartate | 1 |
| 114 | agonist/δ-opioid | 1 |
| 115 | alchemist | 2 |
| 116 | allyloxy | 5 |
| 117 | alpha-antagonist | 9 |
| 118 | alpha2-antagonist | 2 |
| 119 | ammonis1 | 1 |
| 120 | antagonist | 4,813 |
| 121 | antagonist+dexamethasone | 1 |
| 122 | antagonist+dexamethasone+aprepitant | 1 |
| 123 | antagonist-assisted | 3 |
| 124 | antagonist-based | 14 |
| 125 | antagonist-exposed | 1 |
| 126 | antagonist/letrozole | 2 |
| 127 | antagonist/long-acting | 1 |
| 128 | antagonist/nicotine | 1 |
| 129 | antagonists-sb-269970 | 1 |
| 130 | antagonists-treated | 1 |
| 131 | aspersum | 1 |
| 132 | beta-1,3/1,6-d-glucan | 1 |
| 133 | beta-hydroxylase | 11 |
| 134 | beta-selective | 2 |
| 135 | blocker-arb | 1 |
| 136 | blockers-based | 1 |
| 137 | bread/rolls | 1 |
| 138 | bubali | 5 |
| 139 | cd36-related | 1 |
| 140 | channel-activator | 1 |
| 141 | co-agonists | 1 |
| 142 | coagonist | 9 |
| 143 | contanining | 1 |
| 144 | covaginal | 1 |
| 145 | cox-2-inhibitory | 1 |
| 146 | cox=0.065 | 1 |
| 147 | cox=0.126 | 1 |
| 148 | d3-preferring | 2 |
| 149 | daspartate | 1 |
| 150 | deaminase | 60 |
| 151 | deaminases | 1 |
| 152 | degelatinatum | 1 |
| 153 | delta32 | 1 |
| 154 | der1p | 1 |
| 155 | diethanolamine | 1 |
| 156 | differentialt | 1 |
| 157 | diphosphatase | 2 |
| 158 | diphosphate | 258 |
| 159 | diphosphate- | 3 |
| 160 | diphosphate-choline | 1 |
| 161 | diphosphate-glucosyltransferase | 1 |
| 162 | diphosphate-glucuronosyltransferase | 2 |
| 163 | diphosphate-induced | 21 |
| 164 | diphosphate-inducible | 1 |
| 165 | diphosphate-mediated | 2 |
| 166 | diphosphate-n-acetyl-d-glucosamine | 1 |
| 167 | diphosphate-n-acetylglucosamine | 1 |
| 168 | diphosphate-ribose | 5 |
| 169 | down-regulator | 5 |
| 170 | down-regulators | 3 |
| 171 | elaphuri | 5 |
| 172 | epimerase | 1 |
| 173 | err-α-mediated | 1 |
| 174 | f2α-based | 1 |
| 175 | fold-shift | 3 |
| 176 | gammaagonists | 1 |
| 177 | h2-antagonist | 2 |
| 178 | haloalkyl | 1 |
| 179 | hye | 1 |
| 180 | i1-receptors | 1 |
| 181 | immunocontraception | 1 |
| 182 | imvac=0.2 | 1 |
| 183 | imvac=0.8 | 1 |
| 184 | incretion | 1 |
| 185 | ko-mice | 1 |
| 186 | l335 | 7 |
| 187 | la-40 | 2 |
| 188 | levels.among | 1 |
| 189 | m1-antagonist | 2 |
| 190 | macrorhabdus | 1 |
| 191 | mage-3243-258 | 1 |
| 192 | mimetic | 111 |
| 193 | monophospate | 1 |
| 194 | monophosphate-dependent | 3 |
| 195 | monophosphate-mediated | 1 |
| 196 | monophosphate.mg | 1 |
| 197 | mother-bud | 1 |
| 198 | mri-adaptation | 1 |
| 199 | mullite-type | 1 |
| 200 | mutants-r859h | 1 |
| 201 | nacl/l | 1 |
| 202 | neuromodulator/receptor | 1 |
| 203 | neurone-blocking | 1 |
| 204 | non-ebm | 4 |
| 205 | o-co2 | 1 |
| 206 | ofq | 1 |
| 207 | one-hybrid | 5 |
| 208 | p335 | 4 |
| 209 | p335l | 7 |
| 210 | pancreatic-pituitary | 1 |
| 211 | pantotrichum | 21 |
| 212 | paranitro | 1 |
| 213 | partial-agonist | 2 |
| 214 | phosphate-mediated | 4 |
| 215 | positive/progesterone | 1 |
| 216 | pr+/pr- | 1 |
| 217 | pranobex | 10 |
| 218 | production/oxidation | 1 |
| 219 | pyrene/fe | 1 |
| 220 | r2=.17 | 1 |
| 221 | r=-.40 | 2 |
| 222 | receptor-antagonist | 3 |
| 223 | receptor-antagonistic | 1 |
| 224 | receptor-beta2-agonist | 1 |
| 225 | receptor-is | 1 |
| 226 | receptor-rich | 3 |
| 227 | receptor-sensitive | 2 |
| 228 | receptor/cell | 2 |
| 229 | receptorinhibitor | 1 |
| 230 | receptors-dependent | 1 |
| 231 | receptors-has | 1 |
| 232 | releaser | 11 |
| 233 | response/pr | 1 |
| 234 | rhinoceri | 1 |
| 235 | rice-extract | 1 |
| 236 | s-releasing | 3 |
| 237 | s10ph | 1 |
| 238 | saccharomycopsis | 1 |
| 239 | site/alpha | 1 |
| 240 | soja | 3 |
| 241 | square=0.058 | 1 |
| 242 | squared=0.025 | 1 |
| 243 | squared=0.072 | 1 |
| 244 | squared=0.090 | 1 |
| 245 | squared=0.092 | 1 |
| 246 | squared=0.112 | 1 |
| 247 | squared=0.114 | 1 |
| 248 | ss-hydroxylase | 1 |
| 249 | subtype-3 | 10 |
| 250 | subtype-5 | 1 |
| 251 | sympathicotomies | 1 |
| 252 | t102c | 3 |
| 253 | three-hybrid | 1 |
| 254 | transporter-2 | 1 |
| 255 | treatment× | 1 |
| 256 | tri-phosphate | 2 |
| 257 | triphosphatase | 33 |
| 258 | triphosphate | 233 |
| 259 | triphosphate-citrate | 1 |
| 260 | triphosphate-competitive | 1 |
| 261 | triphosphate-dependent | 6 |
| 262 | triphosphate-induced | 2 |
| 263 | triphosphate-sparing | 1 |
| 264 | triphosphate-stress | 1 |
| 265 | triphosphate-tumor | 1 |
| 266 | two-hybrid | 87 |
| 267 | type-α | 1 |
| 268 | v11.2 | 1 |
| 269 | vps53p | 1 |
| 270 | wesnes | 1 |
| 271 | wild-type/m159c | 1 |
| 272 | xylidide | 2 |
| 273 | α4β7-mediated | 1 |
| 274 | β-hydroxylase | 9 |
| 275 | γ-stimulating | 2 |
| 276 | η2=.087 | 1 |
| 277 | η2=.107 | 1 |
| 278 | η2=.118 | 1 |
| 279 | η2=.199 | 1 |
| 280 | η2=0.005 | 1 |
| 281 | η²=0.12 | 1 |
| 282 | μ-agonist/κ-antagonist | 1 |
| 1 | diphosphate- | 3 |
| 2 | 5'-3-o- | 1 |
| 3 | pr+/pr- | 1 |
| 4 | +0.500 | 1 |
| 5 | =-0.730 | 1 |
| 6 | la-40 | 2 |
| 7 | r=-.40 | 2 |
| 8 | =-0.50 | 1 |
| 9 | =0.660 | 1 |
| 10 | antagonists-sb-269970 | 1 |
| 11 | squared=0.090 | 1 |
| 12 | =.190 | 1 |
| 13 | =0.890 | 1 |
| 14 | 2.10.1 | 1 |
| 15 | =16.1 | 1 |
| 16 | =0.301 | 1 |
| 17 | =0.801 | 1 |
| 18 | =-0.411 | 1 |
| 19 | =0.711 | 1 |
| 20 | 2=0.31 | 1 |
| 21 | 0·461 | 1 |
| 22 | 0·961 | 1 |
| 23 | ammonis1 | 1 |
| 24 | transporter-2 | 1 |
| 25 | imvac=0.2 | 1 |
| 26 | v11.2 | 1 |
| 27 | =-0.12 | 1 |
| 28 | η²=0.12 | 1 |
| 29 | squared=0.112 | 1 |
| 30 | =-0.22 | 2 |
| 31 | delta32 | 1 |
| 32 | =-0.42 | 2 |
| 33 | =-0.52 | 4 |
| 34 | =-0.62 | 4 |
| 35 | squared=0.072 | 1 |
| 36 | squared=0.092 | 1 |
| 37 | =.492 | 1 |
| 38 | o-co2 | 1 |
| 39 | subtype-3 | 10 |
| 40 | =-0.3 | 1 |
| 41 | =-0.843 | 1 |
| 42 | =-0.53 | 5 |
| 43 | =-0.583 | 1 |
| 44 | =5.793 | 1 |
| 45 | =.504 | 1 |
| 46 | squared=0.114 | 1 |
| 47 | 0·424 | 1 |
| 48 | =-0.624 | 1 |
| 49 | 3-1724 | 1 |
| 50 | =-0.34 | 2 |
| 51 | subtype-5 | 1 |
| 52 | η2=0.005 | 1 |
| 53 | squared=0.025 | 1 |
| 54 | =20.35 | 1 |
| 55 | l335 | 7 |
| 56 | p335 | 4 |
| 57 | =-0.55 | 1 |
| 58 | cox=0.065 | 1 |
| 59 | =0.275 | 1 |
| 60 | 0·475 | 1 |
| 61 | +0.585 | 1 |
| 62 | =-0.26 | 1 |
| 63 | cox=0.126 | 1 |
| 64 | =-0.46 | 6 |
| 65 | =-0.56 | 4 |
| 66 | =6.166 | 1 |
| 67 | =-0.466 | 1 |
| 68 | =-0.766 | 1 |
| 69 | =-0.686 | 1 |
| 70 | η2=.107 | 1 |
| 71 | =-0.307 | 1 |
| 72 | r2=.17 | 1 |
| 73 | 1.73-4.27 | 1 |
| 74 | =-0.527 | 1 |
| 75 | =.137 | 1 |
| 76 | =-0.57 | 2 |
| 77 | =.157 | 1 |
| 78 | =-0.87 | 1 |
| 79 | η2=.087 | 1 |
| 80 | /5-ht7 | 1 |
| 81 | imvac=0.8 | 1 |
| 82 | =-0.08 | 1 |
| 83 | =-0.408 | 1 |
| 84 | η2=.118 | 1 |
| 85 | -1438 | 3 |
| 86 | square=0.058 | 1 |
| 87 | mage-3243-258 | 1 |
| 88 | =-0.68 | 1 |
| 89 | =-0.78 | 1 |
| 90 | 1=0.0698 | 1 |
| 91 | =-0.529 | 1 |
| 92 | =-0.39 | 3 |
| 93 | =0.339 | 1 |
| 94 | =0.39-0.59 | 1 |
| 95 | +0.459 | 1 |
| 96 | =-0.569 | 1 |
| 97 | =0.679 | 1 |
| 98 | =.89 | 1 |
| 99 | η2=.199 | 1 |
| 100 | 0·599 | 1 |
| 101 | site/alpha | 1 |
| 102 | soja | 3 |
| 103 | a3beta | 1 |
| 104 | blocker-arb | 1 |
| 105 | t102c | 3 |
| 106 | wild-type/m159c | 1 |
| 107 | 4glcnac | 1 |
| 108 | 2/centromeric | 1 |
| 109 | mimetic | 111 |
| 110 | 2-agonistic | 1 |
| 111 | -antagonistic | 1 |
| 112 | receptor-antagonistic | 1 |
| 113 | diphosphate-induced | 21 |
| 114 | 5'-diphosphate-induced | 1 |
| 115 | triphosphate-induced | 2 |
| 116 | agonist-evoked | 5 |
| 117 | blockers-based | 1 |
| 118 | agonist-based | 1 |
| 119 | antagonist-based | 14 |
| 120 | f2α-based | 1 |
| 121 | antagonist-exposed | 1 |
| 122 | antagonists-treated | 1 |
| 123 | α4β7-mediated | 1 |
| 124 | phosphate-mediated | 4 |
| 125 | diphosphate-mediated | 2 |
| 126 | monophosphate-mediated | 1 |
| 127 | err-α-mediated | 1 |
| 128 | cd36-related | 1 |
| 129 | 3-phosphonylated | 1 |
| 130 | antagonist-assisted | 3 |
| 131 | agonist/δ-opioid | 1 |
| 132 | 2-hybrid | 1 |
| 133 | three-hybrid | 1 |
| 134 | one-hybrid | 5 |
| 135 | two-hybrid | 87 |
| 136 | mother-bud | 1 |
| 137 | ko-mice | 1 |
| 138 | xylidide | 2 |
| 139 | pyrene/fe | 1 |
| 140 | 1a-like | 1 |
| 141 | diphosphate-inducible | 1 |
| 142 | antagonist/letrozole | 2 |
| 143 | diphosphate-choline | 1 |
| 144 | 5'-diphosphocholine | 2 |
| 145 | diethanolamine | 1 |
| 146 | diphosphate-n-acetyl-d-glucosamine | 1 |
| 147 | diphosphate-n-acetylglucosamine | 1 |
| 148 | 5'-diphosphate-n-acetylglucosamine | 1 |
| 149 | -antihistamine | 10 |
| 150 | antagonist/nicotine | 1 |
| 151 | positive/progesterone | 1 |
| 152 | antagonist+dexamethasone | 1 |
| 153 | mullite-type | 1 |
| 154 | beta-hydroxylase | 11 |
| 155 | ss-hydroxylase | 1 |
| 156 | β-hydroxylase | 9 |
| 157 | deaminase | 60 |
| 158 | diphosphate-glucosyltransferase | 1 |
| 159 | diphosphate-glucuronosyltransferase | 2 |
| 160 | 5'-diphospate-glucuronosyltransferase | 1 |
| 161 | epimerase | 1 |
| 162 | 3':5'-monophosphate-phosphodiesterase | 1 |
| 163 | diphosphatase | 2 |
| 164 | triphosphatase | 33 |
| 165 | diphosphate-ribose | 5 |
| 166 | 5'-diphosphoribose | 1 |
| 167 | .high-dose | 1 |
| 168 | 5'phosphosulfate | 1 |
| 169 | tri-phosphate | 2 |
| 170 | diphosphate | 258 |
| 171 | 5'-diphosphate | 7 |
| 172 | 5-diphosphate | 1 |
| 173 | triphosphate | 233 |
| 174 | 5'-triphosphate | 23 |
| 175 | 5'-monophosphate | 26 |
| 176 | 3'5'-monophosphate | 1 |
| 177 | 3',5'-monophosphate | 12 |
| 178 | 5′-monophosphate | 1 |
| 179 | 3׳,5׳-monophosphate | 2 |
| 180 | monophospate | 1 |
| 181 | triphosphate-citrate | 1 |
| 182 | agonist/n-methyl-d-aspartate | 1 |
| 183 | daspartate | 1 |
| 184 | beta-selective | 2 |
| 185 | receptor-sensitive | 2 |
| 186 | triphosphate-competitive | 1 |
| 187 | hye | 1 |
| 188 | a-1438g | 2 |
| 189 | monophosphate.mg | 1 |
| 190 | agonist/hmg | 1 |
| 191 | neurone-blocking | 1 |
| 192 | activity-staining | 1 |
| 193 | contanining | 1 |
| 194 | triphosphate-sparing | 1 |
| 195 | d3-preferring | 2 |
| 196 | s-releasing | 3 |
| 197 | γ-stimulating | 2 |
| 198 | 1-activating | 2 |
| 199 | 2-activating | 1 |
| 200 | 9-activating | 2 |
| 201 | antagonist/long-acting | 1 |
| 202 | agonist-long | 1 |
| 203 | levels.among | 1 |
| 204 | mutants-r859h | 1 |
| 205 | receptor-rich | 3 |
| 206 | s10ph | 1 |
| 207 | bubali | 5 |
| 208 | rhinoceri | 1 |
| 209 | elaphuri | 5 |
| 210 | nacl/l | 1 |
| 211 | p335l | 7 |
| 212 | covaginal | 1 |
| 213 | receptor/cell | 2 |
| 214 | haloalkyl | 1 |
| 215 | non-ebm | 4 |
| 216 | pantotrichum | 21 |
| 217 | aspersum | 1 |
| 218 | degelatinatum | 1 |
| 219 | beta-1,3/1,6-d-glucan | 1 |
| 220 | -lean | 1 |
| 221 | 2-prostaglandin | 1 |
| 222 | production/oxidation | 1 |
| 223 | mri-adaptation | 1 |
| 224 | incretion | 1 |
| 225 | immunocontraception | 1 |
| 226 | paranitro | 1 |
| 227 | der1p | 1 |
| 228 | vps53p | 1 |
| 229 | ofq | 1 |
| 230 | 4/nuclear | 1 |
| 231 | -blocker | 34 |
| 232 | releaser | 11 |
| 233 | triphosphate-tumor | 1 |
| 234 | down-regulator | 5 |
| 235 | channel-activator | 1 |
| 236 | receptorinhibitor | 1 |
| 237 | neuromodulator/receptor | 1 |
| 238 | response/pr | 1 |
| 239 | receptors-has | 1 |
| 240 | sympathicotomies | 1 |
| 241 | wesnes | 1 |
| 242 | deaminases | 1 |
| 243 | 5'-diphosphate-glucuronosyltransferases | 1 |
| 244 | receptor-is | 1 |
| 245 | 3',5'-bis | 1 |
| 246 | saccharomycopsis | 1 |
| 247 | bread/rolls | 1 |
| 248 | down-regulators | 3 |
| 249 | i1-receptors | 1 |
| 250 | triphosphate-stress | 1 |
| 251 | co-agonists | 1 |
| 252 | gammaagonists | 1 |
| 253 | macrorhabdus | 1 |
| 254 | rice-extract | 1 |
| 255 | fold-shift | 3 |
| 256 | differentialt | 1 |
| 257 | antagonist+dexamethasone+aprepitant | 1 |
| 258 | triphosphate-dependent | 6 |
| 259 | monophosphate-dependent | 3 |
| 260 | receptors-dependent | 1 |
| 261 | alchemist | 2 |
| 262 | agonist | 3,687 |
| 263 | receptor-beta2-agonist | 1 |
| 264 | 3-agonist | 1 |
| 265 | partial-agonist | 2 |
| 266 | coagonist | 9 |
| 267 | antagonist | 4,813 |
| 268 | m1-antagonist | 2 |
| 269 | alpha2-antagonist | 2 |
| 270 | h2-antagonist | 2 |
| 271 | alpha-antagonist | 9 |
| 272 | receptor-antagonist | 3 |
| 273 | agonist-antagonist | 13 |
| 274 | μ-agonist/κ-antagonist | 1 |
| 275 | agonist/antagonist | 24 |
| 276 | pranobex | 10 |
| 277 | agonist-possibly | 1 |
| 278 | pancreatic-pituitary | 1 |
| 279 | cox-2-inhibitory | 1 |
| 280 | allyloxy | 5 |
| 281 | treatment× | 1 |
| 282 | type-α | 1 |